Literature DB >> 3911071

Characterization of the muscarinic receptor in human tracheal smooth muscle.

C J van Koppen, J F Rodrigues de Miranda, A J Beld, M W Hermanussen, J W Lammers, C A van Ginneken.   

Abstract

Muscarinic receptors in human tracheal smooth muscle were characterized by radioligand binding and functional studies. Specific [3H]-(-)-quinuclidinylbenzilate ([3H]-(-)-QNB) binding to tracheal smooth muscle membranes was reversible, stereoselective and of high affinity (Kd = 47 +/- 4 pmol/l; RT = 920 +/- 120 fmol/g tissue). Inhibition of specific [3H]-(-)-QNB binding by the M-1 selective antagonist pirenzepine was found to occur at relative high concentrations classifying the muscarinic receptor population as belonging to the M-2 subclass. Inhibition of specific [3H]-(-)-QNB binding by muscarinic agonists revealed the presence of high and low affinity sites in nearly equal proportions. 5'-Guanylylimidodiphosphate converted high affinity sites into low affinity sites although its effect was minimal. Log dose-contraction curves of methacholine had Hill coefficients of 1.10 +/- 0.04 with pD2-values of 6.75 +/- 0.02. Inhibition of specific [3H]-(-)-QNB binding by methacholine, however, was best described by a two binding site model with pKi-values considerably lower. The difference between these affinity values points to the presence of substantial receptor reserve.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3911071     DOI: 10.1007/bf00634245

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Are muscarinic receptors in the central and peripheral nervous system different?

Authors:  A J Beld; S Van Den Hoven; A C Wouterse; M A Zegers
Journal:  Eur J Pharmacol       Date:  1975-02       Impact factor: 4.432

2.  Phenoxybenzamine and dibenamine interactions with calcium channel effectors of the muscarinic receptor.

Authors:  E El-Fakahany; E Richelson
Journal:  Mol Pharmacol       Date:  1981-11       Impact factor: 4.436

Review 3.  The coupling of the neuronal muscarinic receptor to responses.

Authors:  M McKinney; E Richelson
Journal:  Annu Rev Pharmacol Toxicol       Date:  1984       Impact factor: 13.820

4.  Pharmacological responses of human and porcine lung parenchyma, bronchus and pulmonary artery.

Authors:  R G Goldie; J W Paterson; J L Wale
Journal:  Br J Pharmacol       Date:  1982-08       Impact factor: 8.739

5.  Guanine nucleotide sensitivity of muscarinic acetylcholine receptors from rat brainstem is eliminated by endogenous proteolytic activity.

Authors:  R S Aronstam; L M Greenbaum
Journal:  Neurosci Lett       Date:  1984-06-15       Impact factor: 3.046

6.  Muscarinic cholinergic receptors in peripheral lung tissue of normal subjects and of patients with chronic obstructive lung disease.

Authors:  J A Raaijmakers; G K Terpstra; A J Van Rozen; A Witter; J Kreukniet
Journal:  Clin Sci (Lond)       Date:  1984-05       Impact factor: 6.124

7.  Catecholamine- and acetylcholinesterase-containing nerves in human lower respiratory tract.

Authors:  M Partanen; A Laitinen; A Hervonen; M Toivanen; L A Laitinen
Journal:  Histochemistry       Date:  1982

8.  Cholinergic and nonadrenergic mechanisms in human and guinea pig airways.

Authors:  S M Taylor; P D Paré; R R Schellenberg
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-04

9.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

10.  Benzilylcholine mustard and spare receptors in guinea pig ileum.

Authors:  H Siegel; D J Triggle
Journal:  Life Sci       Date:  1982-05-10       Impact factor: 5.037

View more
  6 in total

1.  Segment-dependent expression of muscarinic acetylcholine receptors and G-protein coupling in the equine respiratory tract.

Authors:  G Abraham; C Kottke; H Ammer; S Dhein; F R Ungemach
Journal:  Vet Res Commun       Date:  2006-12-15       Impact factor: 2.459

2.  Beta adrenoceptor binding and induced relaxation in airway smooth muscle from patients with chronic airflow obstruction.

Authors:  C J van Koppen; J F de Miranda; A J Beld; C L van Herwaarden; J W Lammers; C A van Ginneken
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

3.  Functional characterization of muscarinic receptors in murine airways.

Authors:  J Garssen; H Van Loveren; C M Gierveld; H Van der Vliet; F P Nijkamp
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

4.  The M2 selective antagonist AF-DX 116 shows high affinity for muscarine receptors in bovine tracheal membranes.

Authors:  A F Roffel; W G in't Hout; R A de Zeeuw; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

5.  Isolated porcine bronchi provide a reliable model for development of bronchodilator anti-muscarinic agents for human use.

Authors:  G D'Agostino; A M Condino; L Gioglio; F Zonta; M Tonini; A Barbieri
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

6.  In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy.

Authors:  Anna-Maria Ciciliani; Peter Langguth; Herbert Wachtel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.